Although significant overall survival benefits have not been statistically determined, the CCL11-E6E7 saRNA treated group displayed better tumor treatment efficacy, achieving durable complete remission on 7/7 mice (Fig. S2F and G). The gene discussed is CCL11; the disease is neoplasm.